Author

Mia Sandberg Lundblad

Observed names: Lundblad, Mia, M LUNDBLAD, M. Lundblad, M. Sandberg Lundblad, Mia Lundblad

Institution: Medicon Village

Observed institutions: Karolinska University Hospital, Novo Nordisk (Denmark), Karolinska Institutet, Medicon Village

OpenAlex ID: A5072765929

Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population

2005 · Jónrit Halling, Maria S. Petersen, et al. · European Journal of Clinical Pharmacology · 66

Biosynthesis of epoxyeicosatrienoic acids varies between polymorphic CYP2C enzymes

2004 · Mia Sandberg Lundblad, Katarina Stark, et al. · Biochemical and Biophysical Research Communications · 49

Accumulation of celecoxib with a 7-fold higher drug exposure in individuals homozygous for CYP2C9*3

2006 · M LUNDBLAD, S OHLSSON, et al. · Clinical Pharmacology & Therapeutics · 33

Differences in CYP2C9 Genotype and Enzyme Activity Between Swedes and Koreans of Relevance for Personalized Medicine: Role of Ethnicity, Genotype, Smoking, Age, and Sex

2015 · Fazleen H.M. Hatta, Mia Lundblad, et al. · OMICS A Journal of Integrative Biology · 24

Pharmacokinetics of recombinant factor XIII at steady state in patients with congenital factor XIII A‐subunit deficiency

2014 · B. Kerlin, B. Brand, et al. · Journal of Thrombosis and Haemostasis · 24

First-In-Human, Phase 1, Randomized, Dose-Escalation Trial with Recombinant Anti–IL-20 Monoclonal Antibody in Patients with Psoriasis

2015 · Alice B. Gottlieb, James G. Krueger, et al. · PLoS ONE · 23

Pharmacokinetic characterization of recombinant factor XIII (FXIII)‐A2 across age groups in patients with FXIII A‐subunit congenital deficiency

2015 · B. Brand‐Staufer, M. Carcao, et al. · Haemophilia · 13

Clinical Pharmacokinetics of the Anti-Interleukin-20 Monoclonal Antibody NNC0109-0012 in Healthy Volunteers and Patients with Psoriasis or Rheumatoid Arthritis

2015 · Mia Sandberg Lundblad, Rune Viig Overgaard, et al. · Advances in Therapy · 10

A novel quinoline with airway relaxant effects and anti-inflammatory properties

2024 · Jesper Bergwik, Jielu Liu, et al. · Respiratory Research · 9

Characterisation of the novel quinoline RCD405: Relaxant effects on cholinergic and histaminergic tone in human bronchi and small airways

2025 · Paola Rogliani, Clive Page, et al. · British Journal of Pharmacology · 2

Interindividual variation in drug metabolism with focus on polymorphic cytochrome P 450 2C9

2005 · Mia Sandberg Lundblad · Figshare · 1

Combined Immediate‐Release and Extended‐Release Formulation of Sodium Valproate Provides Stable Plasma Levels for Inhibition of Histone Deacetylation

2025 · Nikhil Ahuja, Susanna Kääriäinen, et al. · Clinical Pharmacology in Drug Development

Pharmacological characterization of the relaxant effect of RCD405 in isolated human small airways

2024 · Luigino Calzetta, Clive Page, et al. · European Respiratory Journal

Pharmacological characterization of the relaxant effect of RCD405 in isolated human medium bronchi

2024 · Paola Rogliani, Clive Page, et al. · European Respiratory Journal

Pharmacokinetic Characterisation Of Recombinant FXIII Across Age Groups In Patients With FXIII Subunit A Congenital Deficiency

2013 · Brigitte Brand-Staufer, Manuel Carção, et al. · Blood

2006 · E ELIASSON, M LUNDBLAD · Clinical Pharmacology & Therapeutics

Works count: 19

Citation count: 254

H-index: 9

I10-index: 8